Keywords : Triphala
European Journal of Molecular & Clinical Medicine,
2020, Volume 7, Issue 9, Pages 1133-1140
Aim:To assess the effectiveness of Triphala against gingivitis and periodontitis. Triphala is a mixture of three myrobalans known as Emblica officinalis (Amalaki), Terminalia bellerica (Bibhitaki), Terminalia chebula (Haritaki)
Methods: A search of the PubMed, Google Scholar, Web of Science and Scopus database was conducted.
Results: Triphala possess varying therapeutic potentials. Particularly antimicrobial and anti-inflammatory, anti collagenase and anti oxidant properties are of greater importance in dentistry. Various studies show that Triphala is equally as effective as a standard chemotherapeutic agent that is chlorhexidine in treatment and prevention of gingivitis and periodontitis respectively.
Conclusion: Triphala can be a promising therapeutic agent in treatment of gingivitis and peridontitis with no side effects on long term use.